key: cord-0827201-9zzeeic3 authors: Koudoufio, Mireille; Desjardins, Yves; Feldman, Francis; Spahis, Schohraya; Delvin, Edgard; Levy, Emile title: Insight into Polyphenol and Gut Microbiota Crosstalk: Are Their Metabolites the Key to Understand Protective Effects against Metabolic Disorders? date: 2020-10-13 journal: Antioxidants (Basel) DOI: 10.3390/antiox9100982 sha: 04d2c08ccea957feb12ee6a07dbe911771843406 doc_id: 827201 cord_uid: 9zzeeic3 Lifestyle factors, especially diet and nutrition, are currently regarded as essential avenues to decrease modern-day cardiometabolic disorders (CMD), including obesity, metabolic syndrome, type 2 diabetes, and atherosclerosis. Many groups around the world attribute these trends, at least partially, to bioactive plant polyphenols given their anti-oxidant and anti-inflammatory actions. In fact, polyphenols can prevent or reverse the progression of disease processes through many distinct mechanisms. In particular, the crosstalk between polyphenols and gut microbiota, recently unveiled thanks to DNA-based tools and next generation sequencing, unravelled the central regulatory role of dietary polyphenols and their intestinal micro-ecology metabolites on the host energy metabolism and related illnesses. The objectives of this review are to: (1) provide an understanding of classification, structure, and bioavailability of dietary polyphenols; (2) underline their metabolism by gut microbiota; (3) highlight their prebiotic effects on microflora; (4) discuss the multifaceted roles of their metabolites in CMD while shedding light on the mechanisms of action; and (5) underscore their ability to initiate host epigenetic regulation. In sum, the review clearly documents whether dietary polyphenols and micro-ecology favorably interact to promote multiple physiological functions on human organism. Polyphenols, synthesized in a wide variety of fruits, legumes, and herbs, interestingly serve to protect against biotic and abiotic stresses caused by insects and parasites [1] [2] [3] . However, much attention is presently given to dietary polyphenols in view of their evident health benefits. These phenolic compounds are intrinsically strong free radical scavengers [4] and exhibit obvious potential in alleviating oxidative stress (OxS)-related illnesses. In this context, epidemiological and animal food intervention studies have established a solid association between the consumption of polyphenol-rich foods or beverages and their preventive influence on complex diseases, including insulin resistance (IR) [5] [6] [7] [8] , type 2 actions of their relevant metabolites on cardiometabolic disorders. As dietary polyphenols have limited absorption in the stomach and the small intestine, the unabsorbed polyphenols continue their transit to the colon where they are hydrolyzed, demethylated, decarboxylated, dehydroxylated, and ring fissioned by microbiota. Following these processes, microbial metabolites are subjected to phase II metabolism in the colon and liver, and enter the bloodstream to exert their biological effects, which extend to peripheral organs. Unabsorbed polyphenols and metabolites are excreted in feces, and absorbed microbial metabolites are mostly excreted in the urine. Noteworthy, whereas polyphenols improve microbiota composition, diversity and functions through their prebiotic actions, gut microbiota transform them into efficient bioactive regulators capable of optimizing cardiometabolic health in healthy individuals, while alleviating and mitigating the metabolic syndrome in patients. *Created with Servier Medical Art (A service to medicine provided by Les Laboratoires Servier, 50, rue Carnot-92284 Suresnes Cedex-France. It is well established that plant polyphenols predominantly present as glycosides undergo deglycosylation to their respective lipophilic aglycones, thereby enhancing their absorption through the GI [62, 63] . Whether the stomach plays a significant role remains uncertain until today. To our knowledge, there is little direct in vivo evidence on the contribution of the human stomach to the assimilation of phenolic compounds. It needs to be underlined that in vitro simulation or animal models are the most common sources of information. Table 1 summarizes the results obtained in in vitro and in vivo models as well as in humans. colon where they are hydrolyzed, demethylated, decarboxylated, dehydroxylated, and ring fissioned by microbiota. Following these processes, microbial metabolites are subjected to phase II metabolism in the colon and liver, and enter the bloodstream to exert their biological effects, which extend to peripheral organs. Unabsorbed polyphenols and metabolites are excreted in feces, and absorbed microbial metabolites are mostly excreted in the urine. Noteworthy, whereas polyphenols improve microbiota composition, diversity and functions through their prebiotic actions, gut microbiota transform them into efficient bioactive regulators capable of optimizing cardiometabolic health in healthy individuals, while alleviating and mitigating the metabolic syndrome in patients. *Created with Servier Medical Art (A service to medicine provided by Les Laboratoires Servier, 50, rue Carnot-92284 Suresnes Cedex-France. It is well established that plant polyphenols predominantly present as glycosides undergo deglycosylation to their respective lipophilic aglycones, thereby enhancing their absorption through the GI [62, 63] . Whether the stomach plays a significant role remains uncertain until today. To our knowledge, there is little direct in vivo evidence on the contribution of the human stomach to the assimilation of phenolic compounds. It needs to be underlined that in vitro simulation or animal models are the most common sources of information. Table 1 summarizes the results obtained in in vitro and in vivo models as well as in humans. Stability of phenolic compounds in the stomach dependent on structure. [68] Purified Hesperidin 2S Citrus sinsensis peel extract Digestion in the simulator of human intestinal microbial ecosystem (pH 2.0). No degradation of Hesperidin 2S. Hesperidin is resistant to the degradation in the stomach. [69] Resveratrol caprylic esters Synthesis product Incubation in simulated gastric juice (pH 1.2) + pepsin at 37 • C for up to 2 h. No hydrolysis of resveratrol caprylic esters. Resveratrol caprylic esters are not metabolized in the gastric phase. [70] Limited role of the stomach in flavonoid glycosides. Selective absorption and transport of aglycones. [77] Antioxidants 2020, 9, 982 8 of 50 Purified cocoa procyanidin oligomers, incubated in simulated gastric juice, led to the appearance of dimers and monomers in a time-dependent fashion [64, 65] . Similarly, olive oil polyphenol glycosides, including oleuropein (glycoside of elenolic acid linked to hydroxytyrosol) underwent rapid and time-dependent hydrolysis, yielding appreciable amounts of free hydroxytyrosol and tyrosol, probably through nucleophilic attack [66] . On the contrary, other studies, using the same in vitro model, along with oral administration of polyphenols to humans, showed stability of a variety of polyphenols in the acidic milieu [67] [68] [69] [70] [71] [72] [73] . Interestingly, the incubation of apple phloretin and quercetin for 5 min with native saliva resulted in the production of the respective aglycones, likely by oral bacterial flora as the process was blocked by antibiotics [68] . In the same study, hydroxycinnamic acid derivatives, flavonols, dihydrochalcones, and monomeric flavan-3-ols were stable when incubated with simulated gastric juice at pH 1.8, but procyanidin B 2 was degraded. Obviously, the in vitro models suffer from being an inadequate reflection of the gastric fluid, which lacks mucus normally secreted by parietal cells. This is supported by the notable stability of cocoa procyanidin polymers in vivo in the human stomach environment [73] . In terms of in vivo studies, the in situ digestion rat pylorus ligated model shows that polyphenol aglycones are absorbed by the stomach, and suggests the limited role of the stomach in flavonoid glycosides metabolism [74] [75] [76] [77] . These results reveal inequality in the behavior of polyphenols in different experimental models and warrant careful analysis to obtain a complete representation. Using the in vitro three-step model simulating the digestive process from the mouth to the small intestine [78] , it was shown that the duodenal digestion phase either with static or continuous-flow cellulose membrane-based dialysis containing bile salts and pancreatin resulted in dialyzable (chyme-available for passive absorption into the systemic circulation) and non-dialyzable (digested fraction available for colon) fractions [79] . Profiling the chyme and the non-dialyzable procyanidin content of cocoa liquor post gastric digestion revealed that the high-molecular weight procyanidins (pentamers to nonamers) were hydrolyzed essentially into monomers and dimers. Similar profiles were observed for the duodenal digest. Interestingly, the cocoa liquor duodenal digest contained much higher procyanidin concentrations than the cocoa powder counterpart that the authors attributed to the protective effect of fat micellar structures present in the liquor. More recently, using the same dynamic duodenal model, most of the intact procyanidins isolated from chocolate nibs were retained in the non-dialyzable fraction, which would likely be available for colonic digestion by the microbiota, while smaller molecular weight dimers and trimers were quantified in the dialyzable fraction [67] . On the other hand, the addition of carbohydrate-enriched food resulted in lower duodenal digestibility of procyanidin. Last, with the ex vivo reverted duodenal sac model, the bioavailability of curcumin was found to be significantly enhanced when encapsulated in low-and high-molecular weight polylactic-co-glycolic acid nanoparticles, possibly attributable to faster dissolution following the administration [80] . Overall, these results underpin the effect of the food matrix on the metabolism of polyphenols. It is well known that under physiological conditions, the small intestine, particularly the jejunum and ileum segments, represents the principal location for the digestion and absorption of dietary lipids. This holds for polyphenols, although with differing efficiency according to their molecular weight and type of glycosylation. Upon reaching the jejunum and ileum, glycosylated polyphenols are either hydrolyzed into their respective aglycones by the membrane-bound brush-border lactase phlorizin hydrolase [81] or transported intact by the enterocyte sodium-glucose co-transporter and hydrolyzed by the cytosolic β-glucosidase [82] [83] [84] . The nature of carbohydrate moieties affects the absorption of polyphenols through the small intestine. For instance, whereas glucoside conjugates and their aglycones are absorbed in the small intestine, those containing rhamnose molecules, [e.g., the flavonols hesperidin (hesperidin-7-O-glucosyl-rhamnose) and rutin (quercetin-3-O-glucosyl-rhamnose)], must proceed to the colon where rhamnose will be removed by bacterial rhamnosidase [85] . On the other hand, catechin and epicatechin, monomers of the flavonol family, which are often acylated by gallic acid, are readily absorbed by enterocytes without any deconjugation or hydrolysis [86, 87] . Caco-2 cells, a human colon carcinoma derived cell line, which upon confluence develops enterocyte-like characteristics, have extensively been used as a model for studying lipid and drug metabolism [88] and transport [89] . They also have served as a model for studying the absorption, transport, and metabolism of polyphenols as detailed in Table 2 . Caco-2 cells have been shown to absorb major dietary hydroxycinnamates and diferulates after de-esterification (phase 1 transformation) and conversion into glucuronate, methyl, and sulfate conjugates (Phase 2 transformation) [90] . In 2006, Corona et al. [66] reported that Caco-2 cells transported hyroxytyrosol from the apical to the basolateral compartment, with the appearance of 3-O-methyl-hydroxytyrosol and glutathionyl-hydroxytyrosol in both compartments. They observed a similar transport for tyrosol, without any evidence of further metabolism or transport for oleuropein. The same year, trans-epithelial transport of trans-piceid (3-β trans-resveratrol glucoside) and deglycosylation in trans-resveratrol were reported using human intestinal Caco-2 cell monolayers [82] . The important question in the context of nutrition is whether polyphenols behave similarly when evaluated as single compounds as when assessed in complex mixtures [93, 94] . Su et al. [92] partially answered this question by showing that, in Caco-2 cells, (+)-catechin significantly enhanced the cellular uptake and transport of the isoflavone daidzein-8-C-glucoside, whereas this compound significantly abated that of (+)-catechin, and that inhibition of efflux pumps increased their uptake. Although valuable for screening polyphenol bioavailability, caution should be used when interpreting the data obtained from the Caco-2 cellular model in terms of predictability. Indeed, even if in vitro smaller phenolic derivatives of hesperidin 2S were absorbed, hesperidin conjugates were the main bioavailable moieties in a randomized human controlled study [69] . The intestinal porcine enterocyte cell line (IPEC), a non-transformed non-tumorigenic permanent intestinal cell line derived from the jejunum is another model that merits attention for two main reasons. First, it maintains its differentiated characteristics, and second, there is a close analogy in results obtained in vivo with the porcine model, the closest to the human GI system [95, 96] . To our knowledge, it has seldom been used to study polyphenol absorption. However, a good correlation for the uptake of grape pomace polyphenols was observed between IPEC cells and the duodenum and colon of piglets [97] . In addition, Wan et al. [98] proved functionality of the same in vitro model by showing enhanced the secretion of α-defensins-1 and 2 and reduced the E. coli translocation across a confluent IPEC cells by epigallocatechin-3-gallate, the major polyphenol specie in green tea. ↓ hydroxytyrosol and tyrosol in the apical and ↑ in the basolateral media. Appearance of 3-O-methyl-tyrosol and glutathionyl-hydroxytyrosol in the apical and basolateral compartments. Φ transport of oleuropein from the apical to the basolateral compartment. Hydroxytyrosol transported through the enterocyte apical membrane to the basolateral compartment with formation of conjugates. [66] Incubation with trans-piceid up to 360 min. Bidirectional (apical to basolateral and inverse) transport of trans-piceid. Detectable trans-resveratrol in both chambers. Trans-piceid and its aglycone are transported across the apical side and effluxed by the basolateral membrane. [82] Trans-piceid (Resveratrol 3-β-mono-d-glucoside) V. Vinifera Pre-incubated with ± chrysin (5,7-Dihydroxyflavone) and ± d-saccharic lactone in 6-well plates. Incubated with trans-piceid or transresveratrol 24 h. Appearance of trans-Resveratrol after incubation with trans-piceid. ↑ transresveratrol-glucuronides production in chrysin (UDP-glucuronosyl transferase inducer) treated cells. Trans-piceid undergoes hydrolysis to its aglycone and trans-resveratrol undergoes phase II metabolism within the enterocyte. [82] Quercetin, Purified polyphenols Polyphenols added to the apical chamber and incubation up to 2 h. Apical, cellular, and basolateral compartments collected. Time-dependent ↓ quercetin in apical chamber. Stability of quercetin glycoside in apical chamber. Time-dependent appearance of quercetin glycosides in apical chamber and cellular compartment when quercetin is added. Time-dependent ↑ quercetin glycosides in basolateral compartment and stable low quercetin. Quercetin aglycone is preferentially transported through the enterocyte apical membrane to the basolateral compartment after intracellular conjugation. [84] Time-, concentration-, and temperature-dependent uptake of polyphenols. ↑ uptake when inserted into niosomes. Time-, concentration-, and temperature-dependent transport of polyphenol to the basolateral compartment, ↑ with niosomes. ↓ transport with ATP inhibitor, ↑transport with EDTA and P-glycoproteins and multidrug resistance proteins inhibitors. Temperature dependence of uptake suggested energy-driven process. Deactivation of efflux pumps resulted in increased uptake by apical membrane and efflux in basolateral compartment. [86] Free and methyl esters of Hydroxycinnamic acids (ferulic, sinapic, p-coumaric and caffeic methyl esters), Ethyl esters of 5, Glucuronides of ferulic, sinapic, p-coumaric and caffeic methyl esters, sulfates of ferulic, sinapic, p-coumaric and caffeic methyl esters, ferulic, sinapic, p-coumaric sulfates. Metabolites produced either intra-cellularly and excreted in medium or produced in the medium by secreted phase I and phase II enzymes. Time-and temperature-dependent bidirectional but preferential B-A transport of quercetin and ethylacetate derivative. Transport more efficient for the ethylacetate derivative. P-glycoproteins and multidrug resistance proteins inhibitors. ↑ quercetin permeation coefficient from A-B and ↓ from B-A. Φ on ethylacetate derivative. Quercetin might be a substrate of P-glycoproteins and multidrug resistance proteins, causing the ↓ bioavailability of quercetin. Quercetin ethylacetate derivative exhibited better membrane permeation than parent compound. [91] Time-and concentration-dependent uptake. Catechin enhanced uptake and transcellular transport of puerarin but puerarin inhibited that of catechin. P-glycoproteins and multidrug resistance proteins inhibitors. ↑ polyphenol uptake and transport. Deactivation of efflux pumps resulted in increased uptake by apical membrane and efflux in basolateral compartment. [92] ↑: increase; ↓: decrease; Φ: no effect. Antioxidants 2020, 9, 982 13 of 50 The case of the colon bears some singularity in the sense that there is a reciprocal relationship between polyphenols and colonic microbiota. It has been clearly established that the gut microbiome is a key actor in modulating the production, bioavailability, and biological activities of complex low molecular weight phenolic metabolites grouped under the term polyphenol metabolome [99, 100] . Rarely, the transport of polyphenols by the colon has directly been evaluated as most of the studies employed intestinal cell models displaying features of the small intestine [101] . It is, however, worthy to mention that T84 colon carcinoma cell line monolayers, incubated with ferulic, isoferulic, cinnamic, and hydroxycinnamic acids, as well as with flavonoids, showed appreciable transport from the luminal to the basolateral side [102] . Measurable levels of ferulic glucuronide and sulfate were detected in the apical and basolateral compartments when supplied at supra-physiological concentrations. Other reports bear mostly on the polyphenol anticancerogenic properties without addressing the uptake and transport per se [103] [104] [105] [106] . The enterohepatic cycle is an important mechanism for the bioavailability and disposition of polyphenol aglycones and their metabolites. This is true whether absorbed by the small intestine or the colon (where they undergo in situ phase II enzymatic conversion to their respective methyl, glucuronide, and sulfate conjugates) or delivered to the liver via the portal circulation for further conjugation (before entering the blood stream and being excreted in urine). Alternatively, they enter the bile duct where mixed with bile salts, re-enter the small intestine for either a second-round absorption by enterocytes and transport to the liver, or excretion in the stools [37, [107] [108] [109] . Humans are colonized by a wide array of microorganisms referred to as the microbiota that consists of obligate and facultative anaerobes, mainly targeting the colon [110, 111] . Their main assignment is to provide assistance to their host in digesting food complex polysaccharides and proteins unprocessed in the upper GI tract [112] . The saccharolytic pathway, mainly active in the proximal colon, yields short chain fatty acids, of which acetic, propionic, and butyric acids are the most abundant, as well as lactic acid, CO 2 , methane, and ethanol. The second catabolic pathway responsible for protein fermentation, mainly present in the distal colon, leads to metabolite species such as ammonia, various amines, thiols, phenols, and indoles [113, 114] . The healthy gut ecosystem consists of the anaerobes Bacteroidetes and Firmicutes, the latter contributing to more than 90% of the total bacterial species, and Proteobacteria, Verrucomicrobia, and Actinobacteria accounting for the balance [115] . Diet composition has a definite role in the taxonomic and functional profile of the colon microbiota. For example, several reports have shown that high carbohydrate and fiber intakes are related to higher abundance of 3 enterotypes: Lachnospiraceae, Ruminococcaceae, and Bifidobacteria [116] [117] [118] . For their part, omnivorous women were shown to have a higher abundance of fecal butyrate producing taxa (Clostridium cluster XIVa and Roseburia/Eubacterium) than vegetarians [119] . Intervention studies have also established that changing from a carnivorous diet to a plant-based diet resulted in a gradual decrease in abundance of Bacteroides, a bile-tolerant symbiotic microorganism, and an increase in Firmicutes that preferentially metabolizes plant polysaccharides [120] . Furthermore, population food tradition-related differences in microbiota constitution have been reported; those consuming meat-based diets had higher abundances of Bacteroides than those traditionally consuming plant-based diets [118, 121] . A controlled 10-week-diet intervention, involving overweight volunteers, demonstrated a rapid modification in microbiota species composition despite the inter-individual variation in initial composition [122] . Overall, the results indicate that Bacteroides, together with Alistipes and Parabacteroides, may be the primary proteolytic taxon in the human colon [112] . Of interest, although still poorly understood, evidence is accruing on the influence of dietary polyphenols, perceived as xenobiotics, on the modulation of the colonic microflora and health [123] . They interfere with bacterial cell-to-cell communication and coordinate pathogenic behaviors, two clinically important characteristics with regards to virulence control and wound healing [124, 125] . They also sensitize bacteria to xenobiotics and alter membrane permeability. This is exemplified by the sensitization of methicillin-resistant Staphylococcus aureus to β-lactam through the (−)-epicatechin gallate-mediated alterations of the bacterium cell wall bilayer, and enhanced release of lipotechoic acid from the cytoplasmic membrane [126] . Polyphenols, acting as prebiotics, have also been shown to modulate gut metabolism and immunity as well as inflammatory pathways through the change of T-cell functions, inhibition of mast cell degranulation, and down regulation of inflammatory cytokine responses [127] [128] [129] [130] . Studies in animals and in humans have shown modification of colon microflora by polyphenolic compounds, resulting in growth inhibition of certain bacterial groups while permitting others to flourish [131] [132] [133] . Valuable effects of polyphenols, such as those present in red wine, include among others, enhanced abundance of beneficial bacterium taxa such as Bifidobacterium and Lactobacillus, capable of improving gut barrier protection, Faecalibacterium prausnitzii having anti-inflammatory properties, and Roseburia as a butyrate producer. Interestingly, the proliferation of these bacteria occurred at the expense of the less desirable Escherichia coli and Enterobacter cloacae [134] . Most of the important biological actions resulting from phenolic compounds and microbiota are depicted in Figure 2 . The transformation of polyphenols into bioactive metabolites is tributary to the colonic microflora species. For example, the Firmicutes: Eubacterium ramulus and oxidoreducens, Clostridium orbiscidens and Flavonifractor plautii metabolize the flavonols Kaempferol, Quercetin, and Myricetin by O-deglycosylation and C-ring fission into a series of metabolites comprising protocatechuic, 2-(3,4-dihydroxyphenyl-acetic, 2-(4-hydroxyphenil)-propionic, 3-hydroxyphenylacetic, 3-(3-Hydroxyphenyl)-propionic, 2-(3-hydroxyphenil)-acetic, 2-(3-dihydroxyphenil)-acetic, and 3-(3,4-dihydroxyphenil)-acetic acids as well as short-chain fatty acids (SCFAs) [83, 135, 136] ( Figure 2 ). Furthermore, Enterococcus casseliflavus (Firmicutes) hydrolyzes sugar moieties from quercetin-3-O-glucoside, a process releasing the aglycone and ultimately producing lactic, formic, and acetic acids, together with ethanol [137] . The Actinobacteria: Slackia equolifaciens, Slackia isoflavoniconvertens, Eggerthella lenta, Adlercreutzia equolifaciens, and Bifidobacterium spp metabolize the flavonones Naringenin and Hesperidin through C-ring fission yielding 3-(4-hydroxyphenyl)-propionic, 3-phenylpropionic and hydroxyphenylpropionic acids [135, 136] . Adlercreutzia equolifaciens, Paraeggerthella hongkongensis, Slackia equolifaciens, Slackia isoflavoniconvertens, Bacteroides ovatus, S. intermedius, R. productus, E. sp. Julong, E. faecium EPI1, L. mucosae EPI2, and F. magna, have also been shown convert some the isoflavone daidzein to (S)-equol, a nonsteroidal estrogen-like molecule [((3S)-3-(4-hydroxyphenyl)-7-chromanol)] [108, 137] . Naringenin and Hesperidin through C-ring fission yielding 3-(4-hydroxyphenyl)-propionic, 3phenylpropionic and hydroxyphenylpropionic acids [135, 136] . Adlercreutzia equolifaciens, Paraeggerthella hongkongensis, Slackia equolifaciens, Slackia isoflavoniconvertens, Bacteroides ovatus, S. intermedius, R. productus, E. sp. Julong, E. faecium EPI1, L. mucosae EPI2, and F. magna, have also been shown convert some the isoflavone daidzein to (S)-equol, a nonsteroidal estrogen-like molecule [((3S)-3-(4-hydroxyphenyl)-7-chromanol)] [108, 137] . The polyphenol metabolites, produced by the gut microbiota once absorbed and directed to the target tissues and organs, contribute to the metabolic health, through their antioxidant and antiinflammatory properties, by preventing or reducing the risk of developing several cardiometabolic disorders (CMD), notably the metabolic syndrome (MetS). The increasing prevalence of childhood MetS along with overweight and obesity is a major public health concern in both developed and developing countries. MetS is a key risk factor for the development of T2D, non-alcoholic fatty liver disease, and CVD in early adulthood [138] [139] [140] . MetS is a cluster of interrelated risk factors, including abdominal obesity, dyslipidemia, hypertension, hyperglycemia, and IR, which is triggered by cellular redox imbalance and inflammation as cardinal features [141] [142] [143] . The polyphenol metabolites, produced by the gut microbiota once absorbed and directed to the target tissues and organs, contribute to the metabolic health, through their antioxidant and anti-inflammatory properties, by preventing or reducing the risk of developing several cardiometabolic disorders (CMD), notably the metabolic syndrome (MetS). The increasing prevalence of childhood MetS along with overweight and obesity is a major public health concern in both developed and developing countries. MetS is a key risk factor for the development of T2D, non-alcoholic fatty liver disease, and CVD in early adulthood [138] [139] [140] . MetS is a cluster of interrelated risk factors, including abdominal obesity, dyslipidemia, hypertension, hyperglycemia, and IR, which is triggered by cellular redox imbalance and inflammation as cardinal features [141] [142] [143] . In the last two decades, strategies to limit the deleterious effects of the MetS have been focused on diet regimen containing natural fruits, green vegetables, whole grains, legumes, probiotics, vitamin C, vitamin E, and ω-3 polyunsaturated-fatty acids [20, [144] [145] [146] [147] [148] . Likewise, prebiotics, including polyphenols with their prebiotic potential, have also demonstrated promising effects on IR, glycemia, lipid profile, and CVD [8, 134, 149] . Other multiple studies, involving animal models, have consistently shown that administration of polyphenols, extracted from various sources, increased insulin sensitivity (via measurement of homeostatic model assessment for insulin resistance index, glucose intolerance, or insulin tolerance tests) and decreasing circulating free-fatty acid, triglyceride, cholesterol, C-reactive protein, resistin, and leptin concentrations [150] [151] [152] [153] [154] . At the clinical level, a parallel, double-blinded controlled and randomized 6-week dietary intervention demonstrated that strawberry and cranberry polyphenols improved insulin sensitivity in overweight and obese nondiabetic, insulin-resistant human subjects [8] . There was not a significant improvement of other cardiometabolic risk factors, which is probably due to the length of the intervention. Nevertheless, these in vivo results show the potential clinical preventive and therapeutic impact of polyphenols on human diseases. Considering that impaired redox potential and inflammatory processes are the basis of MetS, polyphenols, identified for their antioxidant and anti-inflammatory properties [155, 156] , appear as suitable candidates for preventing its development. The review of the mechanisms linking polyphenols and alleviation of these features follows. Polyphenols are known as major contributors to the fruit total antioxidant activity [157] . They do so by donation of an electron or hydrogen atom to reactive oxygen, nitrogen, and chlorine species based either on hydrogen atom transfer or single electron transfer by proton transfer [158] . Reacting with the inner side of the plasma membrane hydrophobic compounds, polyphenols impede lipid and protein oxidation, thus protecting the structure, fluidity, and function of the cell membrane [159] . Polyphenols also chelate transition metals as Fe 2+ , thus directly reducing the Fenton reaction and preventing oxidation by highly reactive hydroxyl radicals [160] . Reactive oxygen species (ROS) play leading roles in provoking pan-cellular inflammation. Their action is mediated by the activation of powerful transcription factors such as nuclear redox factor-2 (Nrf2), nuclear factor-kappa B (NF-κB), and activator protein 1 [161] . Under unstressed conditions, inactive Nrf2 is linked to its cytoplasmic regulator actin-anchored Kelch-like ECH-associating protein 1. Due to reactive species accumulation in cells under OxS, Nrf2 dissociates from Kelch-like ECH-associating protein 1, translocates into the nucleus where it modulates antioxidant-responsive elements-mediated transcription cytoprotective genes [162, 163] . Phenolic compounds are able to enhance protective pathways by activating Nrf2. For example, flavonoids induce Nrf2 translocation to the nucleus where it forms heterodimers with the leucine zipper-like transcription factors small musculo-aponeurotic fibrosarcoma proteins, then bind to antioxidant-responsive elements to activate target genes such as Phase II enzymes involved in detoxification [164] . In addition, Zhang et al. [165] , using human breast cells, hepatic human liver cancer cells, and mouse Hepa-1 cells, demonstrated cell-dependent agonist/antagonist effects of several flavonoids on the regulation of aryl-hydrocarbon receptor-mediated signalling pathways. Polyphenols may also suppress pro-oxidative response by down-regulating the synthesis of the pro-inflammatory interleukin-(IL)-1β, tumor necrosis factor-alpha (TNFα), and interferon-gamma. They do so by modulating NF-κB and mitogen-activated protein kinase signaling pathways [166] . Moreover, phenolic compounds can display genoprotective effects, thereby preventing/reversing the progression of various CMD diseases [167] . Through the protection of DNA against OxS damages, some types of polyphenols can promote metabolic health [168] [169] [170] [171] . For example, epigallocatechin gallate and resveratrol exhibit high capacity to decrease DNA double strand breaks, chromosome loss, and DNA deterioration response in H 2 O 2 -induced genotoxicity in cells [172, 173] . A human supplementation trial has also shown the ability of green tea polyphenolic antioxidants to increase the resistance of DNA to oxidation damages [174] . The crosstalk between oxidative and inflammation signalling pathways is important for cell homeostasis and survival. Indeed, overproduction of ROS has been shown to stimulate the release of pro-inflammatory cytokines. Reciprocally, NF-κB controlled genes are able to regulate ROS production [175, 176] . Various studies, particularly those oriented toward cancer, revealed that polyphenols are able to control chronic inflammatory responses at the level of cytokine production, NF-κB-mediated gene expression, and the release of the tumor-suppressing transforming growth factor-beta [177] [178] [179] . Furthermore, closely related to the MetS, our group has more recently demonstrated, in post-confluent Caco-2/15 cells, that polyphenols extracted from dried apple peels (DAPP), containing phenolic acids, flavonol glycosides, flavan-3-ols, and procyanidins prevented iron-ascorbate-mediated lipid peroxidation and counteracted lipopolysaccharide-mediated inflammation as shown by the down regulation of the cytokines TNFα and IL-6, lessening of cyclooxygenase-2 expression, and production of prostaglandin E 2 via the decline of NF-κB. Concomitantly, the alleviation of inflammation was accompanied by the induction of Nrf2 (orchestrating cellular antioxidant defenses and maintaining redox homeostasis) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (the "master controller" of mitochondrial biogenesis) [180] . We later demonstrated that DAPP prevented and alleviated dextran sodium sulfate-induced intestinal inflammation in mice, stimulated antioxidant transcription factors, and improved mitochondrial dysfunction. They also decreased lipid peroxidation and up-regulated antioxidant enzymes, while decreasing the activity of myeloperoxidase, the expression of cyclooxygenase-2, and the production of prostaglandin E2. Moreover, DAPP partially restored mitochondrial redox homeostasis, fatty acid β-oxidation, ATP synthesis, apoptosis, and regulatory mitochondrial transcription factors [181] . As DAPP in parallel decreased the relative abundance of Peptostreptococcaceae and Enterobacteriaceae bacteria [182] , it is possible that the modifications of intestinal microbiota brought about the amelioration of oxidative and inflammatory processes. Epigenetic modification of gene expression is extremely important in the modulation of the OxS and inflammatory pathways briefly described above. Such alterations have been associated with abnormalities in various metabolic pathways [183] . Epigenetic control includes methylation of CpG rich regions, post-transcriptional modulation of chromatin histone/non-histone, and micro-RNAs (miRNAs) regulating gene expression [184] [185] [186] . Importantly, while these alterations may persist for cells lifespan and may have inter-generational effects, they are reversible and have thus become prime targets for interventions in the treatment of MetS [187] . Unfortunately, data on these mechanisms, particularly those bearing on DNA methylation and histone acetylation, are scarce. Table 3 shows that, in both animal models and human studies, polyphenol consumption decreases obesity, IR, and hypertension. These metabolic improvements are associated to epigenetic modifications, including increased DNA methylation, and histone methylation and acetylation. Interestingly, reports involving miRNAs are more profuse. Table 4 summarizes the major findings obtained regarding the modulation of miRNAs and their effect on the expression of specific genes. It can be appreciated that polyphenols, independently of their origin, modulate miRNAs, especially controlling OxS and inflammation pathways in different cell models. In animal models, they also regulate miRNAs expression involved in the control of inflammation, obesity, lipogenesis, and energy expenditure. One human study shows that polyphenol consumption modulates miRNAs expression related to inflammation processes. In the first part of the present review, we have defined the polyphenols, described their structure, reported their digestion and absorption, elaborated on their mode of action and potential benefits, emphasized their epigenetic regulation, and pointed out their interaction with intestinal microbiota. The goal of the second part is to focus on the polyphenol metabolites, derived from their colonic microbial metabolism and biotransformation. As mentioned above, parent or native polyphenols have glycosidic linkages, which limit their absorption in the small intestine, forcing them to continue their way to the colon. It is in this part of the large intestine that glycosides are cleaved and further metabolized by microbiota to potentially generate more active and better-absorbed metabolites. Using transporters and passive diffusion, the small molecular weight end-products have easy access to the circulation. Hence, the second part of this review is dedicated to specify the biological activity and consequential functional effects of polyphenol metabolites on CMD. Table 5 provides information on the different metabolites issued from colonic digestion and on their pleiotropic effects. Bacterial flavonoid catabolism in the colon follows a generic pattern yielding non-specific metabolites such as hydroxylated phenylpropionic acid (HPPA) and phenylacetic acids (HPAA) that ultimately may be subjected to β-oxidation and glycination to yield hippuric acid and its hydroxylated counterpart [34, 217] . It can therefore be appreciated that a relatively small number of degradation products emanate from extremely diverse parent flavonoids. Quercetin (2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one) is supplied by apples, tea, red wine, berries, tomatoes, and onions. This polyphenol has attracted a lot of interest from the biomedical milieu in view of its beneficial properties in prevention-diseases (e.g., T2D, CVD) despite its limited bioavailability because of its low solubility, weak stability in the upper gastrointestinal tract, rapid fast metabolism, and short biological half-life [98] . However, quercetin molecules unable to be absorbed in the small intestine reach the colon, and are metabolized into a series of phenolic acids by luminal bacteria [265] . In fact, the health-promoting properties observed with quercetin could account for by microbiota-mediated metabolites. Quercetin, quercetin 3-O-rutinoside (rutin) and their colon-derived flavonoid metabolites 3,4-dihydroxyphenylacetic acid (3,4-HPAA), 4-hydroxyphenylacetic acid (4-HPAA), 3-hydroxyphenylacetic acid (3-HPAA), and hippuric acid (N-benzoylglycine) have been shown to possess antioxidant and anti-inflammatory properties. On the other hand, when in vitro studies using primary cultures of rat liver parenchymal cells or the human HepG2 hepatoma cell line were treated with t-butylhydroperoxide to produce OxS, the radical scavenging properties were noted only for the parent molecules quercetin and rutin, as well as for 3,4-dihydroxytoluene (3,4-DHT). The metabolites 3-HPAA, 4-HPAA, and hippuric acid remained almost ineffective [208] . Similarly, quercetin and 3,4-DHT showed the potency to inhibit cholesterol synthesis. Another in vitro study, testing the radical scavenging capacity of 3,4-DHPAA, 3-HPAA, and 4-HPPA in human polymorphonuclear cells (stimulated with opsonized zymosan or N-formyl-methionyl-leucyl phenylalanine) revealed that out of the 3 metabolites investigated, only 3,4-DHPAA was active [209] . This radical scavenging capacity is of utmost importance when considering the cell protection from cytotoxicity. Indeed as an adjunct to its radical scavenging properties, 3,4-DHPAA activates phase 2 cytoprotective enzymes (i.e., hemeoxynegese-1, glutathione S-transferase), increases the gene and protein expression of aldehyde dehydrogenase isozymes in mouse hepatoma Hepa1c1c7 cells, and induces nuclear translocation of Nrf2 and aryl hydrocarbon receptor [210, 211] , all involved in controlling cellular REDOX status and in inhibiting cell cytotoxicity. In vitro studies have also established the anti-inflammatory properties of quercetin metabolites. For example, experiments with lipopolysaccharide-stimulated human peripheral blood mononuclear cells showed the modulatory effect of 3,4-DHPPA, 3-HPPA, 3,4-DHPAA, 3-HPAA, and 4-hydroxybenzoic acid on the expression of the central pro-inflammatory cytokines; TNFα, IL-1β, and IL-6. TNFα expression was also significantly decreased by the metabolites 3,4-DHPPA, 3,4-DHPAA, and 4-hydroxy-hippuric acid (4-HHA), whereas 3,4-DHPPA and 3,4-DHPAA only suppressed secretion of IL-1β and IL-6 [212] . In another study, in which lipopolysaccharide was used to induce inflammation in RAW 264.7 murine macrophage cell line, 3,4-DHT disclosed an anti-inflammatory capacity by modulating the I κB/NF-κB signaling pathway [266] . Surprisingly, very little research has highlighted the potential anti-diabetic properties of colonic metabolites derived flavonoids. However, when the ability of DHPAA and HPPA was examined on β cell function, the findings clearly emphasized an elevated glucose-stimulated insulin secretion, high protection against tert-butyl hydroperoxide-induced β cell toxicity, hence better survival and function of β cells [215] . The last functions were mediated by the activation of protein kinase C and the extracellular regulated kinases (ERKs) pathways. Collectively, these interesting data suggest that flavonol quercetin/rutin metabolites exert anti-diabetic actions. Flavones (e.g., apigenin) are present in foods as cereals, parsley, thyme, celery, and citrus fruits under their O-glycosidic or C-glycosides derivatives. Once glucosides are hydrolyzed at the intestinal level by digestive enzymes, unabsorbed aglycons undergo further reactions in the large intestine by specific micro-organisms (Clostridium orbiscindens, Enterococcus avium) causing C-ring fission. Following the metabolism of apigenin, metabolites [e.g., phloretin chalcon, 3-(4-hydroxyphenyl)-propionic, 3-(3-hydroxyphenyl)-propionic, and 4-hydroxycinnamic acids] are acquired [221] . Flavanones (e.g., naringenin) are abundant in tomatoes and citrus fruits, and seem to have higher bioavailability in comparison to flavonols and flavan-3-ols [267] . Flavanone deglycosylation and further degradation by colonic microbiota pathways follow the similar fate of flavonols [267] . Clostridium species and Eubacterium ramulus are largely involved in these transformations in the colon [217, 268] . Metabolites, including 3-(3,4-dihydroxyphenyl)-propionic, 3-(4-hydroxyphenyl)-propionic, and 3-(3-hydroxyphenyl)-propionic acids are produced following naringenin metabolism. However, as for quercetin metabolites, hydroxyphenyl propionic acids (derived from apigenin and naringenin metabolism) display antioxidant and anti-inflammatory capacities (Table 5) . Isoflavone, as a phytoestrogen precursor, is another flavonoid class of interest. Like many types of polyphenols, isoflavones exert advantageous effects on intestinal health, menopause symptoms, hormone-mediated syndromes, and CVD [269] . They are also transformed into their active metabolites by enzymes from the gut microbiota to generate compounds endowed with elevated estrogenic activity (e.g., 4 ,7-isoflavandiol; equol) or inactive compounds (e.g., O-desmethylangolensin; O-DMA) [270] . Importantly, the majority of humans are competent to yield O-DMA, but only 25-50% among them engender equol [271, 272] . The potential health properties of equol and O-DMA, both derived from daidzein and its 7-O-glycoside daidzin, are the subject of continuing debate. Some studies claim their beneficial effects on the risk of coronary heart disease events [273, 274] and others have shown a limited action [275] . The diverging conclusions stems in part from the inter-individual variability in the gut microbiota [276] or from a characteristic that is influenced by ethnicity [277] . Interestingly enough, prehypertensive postmenopausal women producing equol/O-DMA had more favorable cardiovascular risk profiles than non-producers [278] . Furthermore, equol/O-DMA producers exhibited lower serum uric acid, triglycerides, and waist/hip ratio, as well as a tendency to have higher high density lipoprotein-cholesterol compared to equol non-producers [279] . These effects are probably exerted through the control of cell redox potential as both equol and O-DMA have antioxidant capacity, exemplified by the stimulation of catalase and total superoxide dismutase activities [226] . In a population-based, cross-sectional investigation, urinary concentrations of isoflavones and equol/O-DMA were related to well-disposed insulin sensitivity and cardiometabolic markers in pregnant women [280] . Other studies emphasized the beneficial role of O-DMA in obesity [281] . However, caution should be exerted when concluding on the effects of isoflavone and related metabolite interventions, as sufficiently randomized controlled trials with statistical are needed [275] . Flavanols or flavan-3-ols are among the most consumed phenolic compounds in Western populations [282] . They are composed of monomers (e.g., catechin, epicatechin, epigallocatechin) and oligomers/polymers (known as proanthocyanidins) [283] . Several groups have reported their ability to prevent chronic diseases (e.g., T2D and CVD) [283] [284] [285] . Hydroxy-phenyl-γ-valerolactones and their related hydroxy-phenylvaleric acids are the main metabolites of dietary flavan-3-ols [87, 286] . Although a number of studies based on different models aiming at assessing hydroxy-phenyl-γ-valerolactones bioactivity have been reported in the past decade, those involving human subjects are scarce. Inflammatory and OxS processes were particularly studied. For example, (3 4 -dihydroxyphenyl)-γ-valerolactone significantly decreased TNFα-induced NF-kB transcriptional activity in HepG2 cells [92] . Furthermore, a decrease was noted in nitrous oxide production and inducible nitrous oxide synthase expression in the murine macrophage RAW264.7 cells and freshly isolated human monocytes, both treated with (δ-(3,4-dihydroxyphenyl)-γ-valerolactone) a metabolite of the maritime pine bark Pycnogenol [233] . The accumulation of pro-inflammatory cytokine-producing T-lymphocytes and macrophages with the concomitant secretion of the vascular cell-adhesion molecule-1 by the endothelium is key to the early development of the atherosclerotic plaque [287] . Inhibition of this process was observed following the incubation of cultured human umbilical vein endothelial cells with 3 ,4 -dihydroxyphenyl)γ-valerolactone [234] , thereby providing the evidence that this compound is a potential therapeutic target. Transferability of the concentrations (quantities) of natural compounds to in vivo or clinical environment (cytotoxicity) represents a major limit of these in vitro experiments. The polyphenolic metabolites 3 ,4 ,5 -trihydroxyphenyl)-γ-valerolactone and 5-(3 ,5 -dihydroxyphenyl)-γ-valerolactone also displayed, in spontaneously hypertensive rats, the capacity to lower angiotensin-1 converting enzyme activity and blood pressure, both contributing to improving endothelial function and arterial elasticity [235] . Paradoxically, the flavan-3-ol metabolites 5-(3 ,4 ,5 -trihydroxyphenyl)-γ-valerolactone, 5-(3 ,4 -dihydroxyphenyl)-γ-valerolactone, and 5-(3 -methoxy, 4 -hydroxyphenyl)-γ-valerolactone did not improve vascular endothelial plasticity of freshly isolated mouse saphenous arteries [236] . The dissimilarity in data could partially be explained by the different models used, especially that isolated saphenous artery endothelium is less reactive than the vessels of the spontaneously hypertensive rat. The in vivo versus the in vitro situations and the experimental time frame are also factors that have to be considered. The decrease in obesity, a major element in the development of MetS, in response to the consumption of foods rich in flavan-3-ols (e.g., green tea), has been attributed to the role of their content on polyphenolic metabolites in increasing energy expenditure via the modulation of cell differentiation and thermogenesis in adipose tissues [231] . However, when tested in vitro, the flavan-3-ol metabolites [231] . In a recent clinical trial, Rodriguez-Mateos et al. [288] showed that cranberry juice given to healthy volunteers improved, in a concentrationand time-dependent manner, the flow-mediated vasodilatation, an early clinical sign in the development of atherosclerosis. Interestingly, the plasma level of the flavan-3-ols metabolite, 5-(3 -hydroxyphenyl)-γ-valerolactone-4 -sulfate, was significantly positively correlated to flow-mediated vasodilatation. Noteworthy, mice on high-fat diet improved non-alcoholic fatty liver disease by lessening IR and endotoxin-toll-like receptor 4/NF-κB pathway in response to raised hepatic catechin metabolites (namely phenyl-γ-valerolactones) following catechin-rich green tea extract [289] . Overall, these findings offer promising beneficial health effects of polyphenols metabolites. However, additional clinical studies are necessary to validate the data in humans and to ensure their transferability from in vitro and animal models to in vivo human situations. Hydrolysable tannins, named ellagitannins, encompass one or more gallic acid units and one or more hexahydroxydiphenoic acid units, ester-connected with a sugar residue. In view of their difficulty to be absorbed in the small intestine, ellagitannins reach the colon where they are hydrolyzed into mainly ellagic acid and urolithin (3,4-benzocoumarin derivatives) . Supporting data propose a stringent relationship between the consumption of ellagitannins-rich foods and healthy effects based on animal and human models. The rat under high carbohydrate high-fat diet-induced MetS model has demonstrated the ability of ellagic acid to improve hepatic and cardiometabolic functions, while normalizing glucose tolerance, blood lipid components, central obesity, and body weight [290] . The mechanisms involved in the modulation of OxS and inflammation are through the protein level regulation of Nrf2 and NF-κB, with an impact on metabolic pathways such as fatty acid β-oxidation [290] . Other studies confirm the health benefit properties of ellagic acid, for example, by showing that it dose-dependently repressed the IL-1β-induced production of ROS [248] . This was associated with a significant reduction of the attachment of the established human monocyte cell line to IL-1β-treated human umbilical vein endothelial cells through the suppression of NF-κB, thereby downregulating the expression of vascular cell-adhesion molecule-1 and E-selectin and resulting in decreased monocyte adhesion. Along the same line of evidence, ellagic acid significantly inhibited oxidized low-density lipoprotein and platelet-derived growth factor-BB-induced proliferation of rat aortic smooth muscle cells via inactivation of ERK and marked decrease of proliferating cell nuclear antigen. [249] . More evidence for ellagic acid effects in preventing the development of atherosclerotic events has been provided by showing its capacity of reducing platelet growth factor (PDGF) receptor-β-phosphorylation, diminishing ROS production, and lessening downstream activation of ERK, and finally blocking platelet-derived growth factor-induced expression of cyclin D1 in primary cultures of rat aortic smooth muscle cells [291] . Moreover, these in vitro results were further supported by the ability of ellagic acid to block T2D-induced medial thickness, and lipid and collagen deposition in the arch of aorta in streptozotocin-induced diabetic rats [291] . Collectively, these data suggest that ellagic acid can inhibit OxS and inflammation response, which thus favorably contributes to the regulation of vascular homeostasis. Urolithins, formed primarily from the oxidative linkage of galloyl groups, have extensively emerged as novel natural bioactive compounds, being currently the focus of extensive investigations. The type of urolithin produced depends on the colon microbiome. Three ellagitanninsmetabolizing metabotypes have been identified: 'metabotype A' (producers of the dihydoxylated urolithin-A conjugates), 'metabotype B' (producers of urolithin-A/isourolithin-A conjugates and/or monohydoxylated urolithin-B conjugates), and 'metabotype 0 (no urolithins produced) [292] . Contrary to the parent compounds, which bloodstream concentrations are negligible, these ellagic acid derivatives may reach micromolar concentrations and thus act as surrogate biomarkers of the inter-individual variation in the colon metabotype [245] . Among the numerous metabolites, urolithin-A has been particularly studied in terms of its anti-inflammatory and anti-oxidative properties both in vitro and in vivo [250, 293, 294] , as well as anti-atherosclerotic and anti-angiogenic activities [293, 295] . In line with these features, adhesion model involving established human aortic endothelial cells and human leukemia monocytic THP-1 cells showed that urolithin-A inhibited TNFα-stimulated adhesiveness and endothelial cell migration [257] . To delve deeper and uncover the mechanisms, the authors could further demonstrate that these effects were concomitant to a down regulation of the levels of chemokine ligand 2, plasminogen activator inhibitor-1, and IL-8. Even more interesting, a clinical trial provided evidence that overweight-obese individuals consuming ellagitannin-containing food with the urolithin metabotype producing urolithin-A were protected against CMD when compared to those with a urolithin-B metabotype [296] . Despite the small number of participants, this clinical trial pointed out the important inter-individual disparity in metabolizing polyphenols, the regulation by microbiota, and indicated that urine metabolite profiling is a valuable tool in assessing potential effects. Fecal polyphenol metabolite profiling could also shed some light on the mechanisms of action. In this context, the profile of fecal phenolic-derived metabolites correlated to blood biomarkers of OxS and inflammation, thus providing support to this avenue [297] . Urolithin may constitute a central regulator of CMD as IR decreased in response to urolithin administration to mice fed high-fat, high-sucrose diet [298] . Concomitantly, urolithin lowered glucose, fatty acids, and triglycerides, while ameliorating adiponectin and mitochondrial function. Furthermore, in the same animal model, through thyroid hormone modulation, urolithin increased energy expenditure by enhancing thermogenesis in brown adipose tissue and inducing browning of white adipose tissue [299] . Therefore, this first-in-class natural compound contributed to metabolic homeostasis via its capacity to normalize OxS, inflammation, obesity, and IR, which overall contribute to MetS. Plant lignans are non-flavonoids, but polyphenolic, phytoestrogenic compounds. They exhibit several biological functions with potent protective benefits. Anti-estrogenic, antioxidant, anti-inflammatory, anti-atherosclerotic, and anti-carcinogenic effects are among their properties, thereby conferring therapeutic values [300, 301] . These properties explain the impact of lignan-rich diets on the prevention of hyperlipidemia, IR and hyperglycemia, T2D, and CMD [302] [303] [304] . The most frequent forms of dietary lignans are secoisolariciresinol, lariciresinol, pinoresinol, and matairesinol, which are metabolized by gut microflora enzymes into enterolignans such as enterodiol and enterolactone undergoing enterohepatic circulation [305, 306] . At least, 28 bacterial species belonging to 12 different genera (e.g., Bacteroides, Clostridium, Bifidobacterium, and Ruminococcus) have been identified to be involved in the transformation of lignans to enterolignans [307] . Several groups have quantified the concentrations of the enterolactone metabolite in blood and urine, and reported a protective association in view of the reduction (30-45%) of cardiovascular mortality [308] . Similarly, in a prospective investigation, enterolactone (more than enterodiol) was associated with a lower risk of T2D in U.S. women [309] . A cross sectional trial of the general U.S. population found that subjects with high excretion of enteractone had lower odds of having MetS [310] . Moreover, in a representative sample of U.S. adults, the cross-sectional analysis of data detected that urinary enterolignan concentrations are associated with lower serum triglyceride and greater high-density lipoprotein-cholesterol concentrations in U.S. adults [311] . Additional efforts are obviously needed to confirm these interesting cardiometabolic findings and to explore potential mechanisms of action behind diverse enterolignan metabolites. Resveratrol (3,5,4 -trihydroxystilbene) belongs to the stilbene derivative and is a dietary polyphenolic compound accessible in 70 plant species such as grapes, mulberries, and peanuts [312] . Its pleiotropic effects have made it so famous that it is called a star molecule. It displays numerous biological activities, including antioxidant, anti-inflammatory, cardioprotective, anti-aging, and cancer-chemopreventive features [313, 314] . Accordingly, the wealth of scientific reports revealed the effectiveness and beneficial actions of resveratrol in MetS and related disorders such as obesity, IR, and T2D [315, 316] ). For example, a meta-analysis evaluating 11 studies involving 388 T2D subjects mentioned that resveratrol markedly lessened fasting glucose, insulin, haemoglobin A1c, and IR [278] . Resveratrol was also able to improve hypertension by acting on vascular nitric oxide production, reducing endothelial dysfunction and arteriolar remodeling [317, 318] . However, other studies could not record advantageous data on MetS in response to resveratrol [319] . Today, it is well established that resveratrol is easily absorbed by the intestine and promptly metabolized to produce glucuronide and sulfate conjugates [320, 321] . Although many gaps are still persistent in the metabolic route of resveratrol, intestinal bacteria transform resveratrol into dihydroresveratrol, known to be partially absorbed and subsequently metabolized to conjugated forms, which can be excreted in urine [322, 323] . Besides dihydroresveratrol, two additional bacterial trans-resveratrol metabolites were identified: 3,4 -dihydroxy-trans-stilbene and 3,4 -dihydroxybibenzyl (lunularin) [264] . Large inter-individual variation was noticed in different subjects: some of them were lunularin producers, others were dihydroresveratrol producers, and the last category was mixed producers, according to levels of these metabolites [264] . Clearly, there was a close relationship between lunularin producers and the abundance of Bacteroidetes, Actinobacteria, Verrucomicrobia, and Cyanobacteria, along with lower abundance of Firmicutes compared to dihydroresveratrol or mixed producers [264] . Whether resveratrol metabolites are physiologically relevant to tackle metabolic disorders still remains an enigma. Consuming a diet rich in fruits and vegetables is associated with a reduced risk of several noncommunicable lifestyle-related diseases, including CVD. They contribute several essential and bioactive micronutrients such as polyphenols. The first goal of this review was to focus on the available and pertinent literature, which assessed the health-promoting potential of polyphenols to modulate OxS and inflammation. These two major components are powerful inducers of IR, leading to CMD, especially MetS and related complications such as T2D and atherosclerosis. For the reader's benefit, our review first summarized the most widely distributed classes, sources, and properties of the naturally occurring polyphenols, separated into two main groups, flavonoids and non-flavonoid compounds. Second, attention was paid to their transformation in the intestinal lumen, absorption in different regions of the GI tract, and their bioavailability in the bloodstream. Clearly, most of polyphenols undergo complex intraluminal transformation during digestive and absorptive processes. Data obtained from critical literature revision underline the poor bioavailability, aqueous solubility, permeability, and instability of especially polyphenols with high molecular weights. Third, considerable emphasis was devoted to the essential polyphenol-microbiota interaction as polyphenols directly exert their regulatory effects on intestinal bacteria with concomitant biotransformation of polyphenols into metabolites by gut microbiota. This fundamental interplay provides the central explanation as to the stupefying pleiotropic biological/clinical actions and functions of "parent" polyphenols whereas their systemic bioavailability is incredibly limited, which highlights the prominent contribution of polyphenol metabolites. Fourth, the multifaceted actions and functions of ''parent" polyphenols were summed up. Not only do polyphenols show the great ability to regulate cellular, molecular, and physiological pathways in relation with OxS and inflammation, but they also exhibit a remarkable effectiveness in improving cardiometabolic biomarkers to the advantage of human health. Thanks to their anti-obesogenic, -hyperlipidemic, -hypertensive, -IR, -atherosclerotic, as well as -diabetic effects, they may help to prevent and treat CMD as global public health problems with vast mortality and economic consequences. Fifth, although polyphenol metabolites were also shown to play a similar beneficial role in metabolic complications, there are various enigmatic issues to deal with: inter-individual differences in the microbial conversion of parent polyphenols, largely unknown Enhancement of polyphenolic metabolism as an adaptive response of lettuce (Lactuca sativa) roots to aluminum stress Role of phenolic compounds during antioxidative responses of winter triticale to aphid and beetle attack Bio-insecticidal effects of Oleaster leaves aqueous extracts against Psylla larvae (Euphyllura olivina (Costa)), a primary pest of Olea europaea L Characterization of polyphenols and evaluation of antioxidant capacity in grape pomace of the cv A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial Strawberry and cranberry polyphenols improve insulin sensitivity in insulin-resistant, non-diabetic adults: A parallel, double-blind, controlled and randomised clinical trial Recent advances in understanding the anti-diabetic actions of dietary flavonoids The Antidiabetic Mechanisms of Polyphenols Related to Increased Glucagon-Like Peptide-1 (GLP1) and Insulin Signaling The role of anthocyanins as antidiabetic agents: From molecular mechanisms to in vivo and human studies Carob fruit extract-enriched meat improves pancreatic beta-cell dysfunction, hepatic insulin signaling and lipogenesis in late-stage type 2 diabetes mellitus model Novel insights of dietary polyphenols and obesity Antiobesity Effect of Prebiotic Polyphenol-Rich Grape Seed Flour Supplemented with Probiotic Kefir-Derived Lactic Acid Bacteria Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors Evidences of the cardioprotective potential of fruits: The case of cranberries Evidence that cranberry juice may improve augmentation index in overweight men The Mediterranean Diet and Cardiovascular Health Anti-atherosclerotic and cardiovascular protective benefits of Brazilian nuts Characterization of Novel Synthetic Polyphenols: Validation of Antioxidant and Vasculoprotective Activities Polyphenols as an Effective Therapeutic Intervention Against Cognitive Decline During Normal and Pathological Brain Aging The Potential for Natural Antioxidant Supplementation in the Early Stages of Neurodegenerative Disorders Polyphenols from Food and Natural Products: Neuroprotection and Safety Polyphenol-rich extract from grape and blueberry attenuates cognitive decline and improves neuronal function in aged mice Tea and Its Components Prevent Cancer: A Review of the Redox-Related Mechanism Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity Natural productderived phytochemicals as potential agents against coronaviruses: A review May phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (Covid-19)? The metabolic fate of dietary polyphenols in humans. Free Radic Bioavailability of the polyphenols: Status and controversies Extraction Methods, Antioxidative Action, Bioavailability and Anticarcinogenic Effects Role of Intestinal Microbiota in the Bioavailability and Physiological Functions of Dietary Polyphenols Benefits of polyphenols on gut microbiota and implications in human health Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance Dietary phenolics: Chemistry, bioavailability and effects on health Chemistry and biochemistry of dietary polyphenols Proanthocyanidins and hydrolysable tannins: Occurrence, dietary intake and pharmacological effects Effects of non-covalent interactions with 5-O-caffeoylquinic acid (chlorogenic acid) on the heat denaturation and solubility of globular proteins Covalent interactions between amino acid side chains and oxidation products of caffeoylquinic acid Interactions between polyphenols and macromolecules: Quantification methods and mechanisms Influence of cultivar, harvest time, storage conditions, and peeling on the antioxidant capacity and phenolic and ascorbic acid contents of apples and pears Phenolic and volatile compounds of extra virgin olive oil (Olea europaea L. Cv. Cornicabra) with regard to fruit ripening and irrigation management Qualitative and semiquantitative analysis of phenolic compounds in extra virgin olive oils as a function of the ripening degree of olive fruits by different analytical techniques Flavonoids in food and their health benefits Rapid analysis of procyanidins and anthocyanins in plasma by microelution SPE and ultra-HPLC Characterization of bioactive cranberry fractions by mass spectrometry Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice Health-promoting compounds in broccoli as influenced by refrigerated transport and retail sale period Total Phenolic, Phenolic Acid, Anthocyanin, Flavan-3-ol, and Flavonol Profiles and Antioxidant Properties of Pinto and Black Beans (Phaseolus vulgaris L.) as Affected by Thermal Processing Effect of Thermal Treatment on Radical-scavenging Activity of Some Spices Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration The Bioavailability, Transport, and Bioactivity of Dietary Flavonoids: A Review from a Historical Perspective Urinary metabolites as biomarkers of polyphenol intake in humans: A systematic review Polyphenols: Food sources and bioavailability Metabolism of dietary procyanidins in rats. Free Radic Metabolism of flavonoids in human: A comprehensive review The Gastrointestinal Tract as Prime Site for Cardiometabolic Protection by Dietary Polyphenols Decomposition of cocoa procyanidins in the gastric milieu Stability of the flavan-3-ols epicatechin and catechin and related dimeric procyanidins derived from cocoa The fate of olive oil polyphenols in the gastrointestinal tract: Implications of gastric and colonic microflora-dependent biotransformation Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models Intestinal transit and systemic metabolism of apple polyphenols A Critical Evaluation of In Vitro Hesperidin 2S Bioavailability in a Model Combining Luminal (Microbial) Digestion and Caco-2 Cell Absorption in Comparison to a Randomized Controlled Human Trial Stability of resveratrol esters with caprylic acid during simulated in vitro gastrointestinal digestion In Vitro Digestion of Apple Tissue Using a Dynamic Stomach Model: Grinding and Crushing Effects on Polyphenol Bioaccessibility Nutritional properties and biological activities of kiwifruit (Actinidia) and kiwifruit products under simulated gastrointestinal in vitro digestion Cocoa procyanidins are stable during gastric transit in humans Phenolic acids are absorbed from the rat stomach with different absorption rates Distribution pattern of a flavonoid extract in the gastrointestinal lumen and wall of rats Daidzein and genistein but not their glucosides are absorbed from the rat stomach Quercetin, but not its glycosides, is absorbed from the rat stomach An in vitro method to simulate phenolic compound release from the food matrix in the gastrointestinal tract Effect of fat content on the digestibility and bioaccessibility of cocoa polyphenol by an in vitro digestion model Effects of polymer molecular weight on relative oral bioavailability of curcumin Absorption of quercetin-3-glucoside and quercetin-4'-glucoside in the rat small intestine: The role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells Flavonoid metabolism: The interaction of metabolites and gut microbiota Efficiency of Absorption and Metabolic Conversion of Quercetin and Its Glucosides in Human Intestinal Cell Line Caco-2 Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria Enhanced uptake and transport of (+)-catechin and (−)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells Absorption, metabolism, distribution and excretion of (−)-epicatechin: A review of recent findings Caco-2 cells and human fetal colon: A comparative analysis of their lipid transport Intestinal transport as a potential determinant of drug bioavailability Characterization of metabolites of hydroxycinnamates in the in vitro model of human small intestinal epithelium caco-2 cells Esterification of Quercetin Increases Its Transport across Human Caco-2 Cells Absorptive interactions of concurrent oral administration of (+)-catechin and puerarin in rats and the underlying mechanisms Potentiation of the bioavailability of blueberry phenolic compounds by co-ingested grape phenolic compounds in mice, revealed by targeted metabolomic profiling in plasma and feces Modulation of Strawberry/Cranberry Phenolic Compounds Glucuronidation by Co-Supplementation with Onion: Characterization of Phenolic Metabolites in Rat Plasma Using an Optimized muSPE-UHPLC-MS/MS Method Animal models for determining amino acid digestibility in humans-A review The IPEC-J2 Cell Line Pistol, G.C.; Taranu, I. Intestinal Absorption and Antioxidant Activity of Grape Pomace Polyphenols The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review The absorption, distribution, metabolism and excretion of procyanidins Systematic analysis of the polyphenol metabolome using the Phenol-Explorer database The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models The Ussing type chamber model to study the intestinal transport and modulation of specific tight-junction genes using a colonic cell line Polyphenol-Enriched Plum Extract Enhances Myotubule Formation and Anabolism while Attenuating Colon Cancer-induced Cellular Damage in C2C12 Cells Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells Comprehensive foodomics study on the mechanisms operating at various molecular levels in cancer cells in response to individual rosemary polyphenols Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols Bioavailability of dietary polyphenols and gut microbiota metabolism: Antimicrobial properties Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites Microbes in gastrointestinal health and disease The gut microbiota and metabolic disease: Current understanding and future perspectives Trade-Off between Saccharolytic and Proteolytic Fermentation Contributions of the Interaction Between Dietary Protein and Gut Microbiota to Intestinal Health Dietary Protein and Gut Microbiota Composition and Function A human gut microbial gene catalogue established by metagenomic sequencing Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans Linking long-term dietary patterns with gut microbial enterotypes Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity Faecal microbiota composition in vegetarians: Comparison with omnivores in a cohort of young women in southern India Diet rapidly and reproducibly alters the human gut microbiome Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa Dominant and diet-responsive groups of bacteria within the human colonic microbiota Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency Tea polyphenols as an antivirulence compound Disrupt Quorum-Sensing Regulated Pathogenicity of Pseudomonas aeruginosa Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment The beta-lactam-resistance modifier (−)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus Immunomodulation by food: Impact on gut immunity and immune cell function Immunological Tolerance and Function: Associations Between Intestinal Bacteria Antioxidant and Anti-Inflammatory Properties of a Thuja occidentalis Mother Tincture for the Treatment of Ulcerative Colitis Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer Effect of Proanthocyanidin-Rich Extract from Grape Seeds on Human Fecal Flora and Fecal Odor Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients Gut microbiota functions: Metabolism of nutrients and other food components Bacterial species involved in the conversion of dietary flavonoids in the human gut The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases Childhood obesity and cardiovascular dysfunction Pediatric Obesity and Cardiometabolic Disorders: Risk Factors and Biomarkers Childhood Obesity and the Metabolic Syndrome Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort Non-alcoholic fatty liver disease severity and metabolic complications in obese children: Impact of omega-3 fatty acids A perspective on vegetarian dietary patterns and risk of metabolic syndrome Whole-grain consumption and the metabolic syndrome: A favorable association in Tehranian adults Management of metabolic syndrome through probiotic and prebiotic interventions Fruit Polyphenols: A Review of Anti-inflammatory Effects in Humans Muscadine grape (Vitis rotundifolia) and wine phytochemicals prevented obesity-associated metabolic complications in C57BL/6J mice Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin-A biochemical study in rats subjected to experimental hyperlipidemia and obesity Raspberry seed flour attenuates high-sucrose diet-mediated hepatic stress and adipose tissue inflammation Role of Polyphenols and Other Phytochemicals on Molecular Signaling Natural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a Target Comparison of phytochemical profiles, antioxidant and cellular antioxidant activities of different varieties of blueberry (Vaccinium spp Antioxidant properties of phenolic compounds: H-Atom versus Elecgron Transfer Mechanism Flavonoid-membrane interactions: A protective role of flavonoids at the membrane surface? A review of the antioxidant mechanisms of polyphenol compounds related to iron binding Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases Healthy dietary patterns to reduce obesity-related metabolic disease: Polyphenol: Microbiome interactions unifying health effects across geography Rosemary Diterpenes and Flavanone Aglycones Provide Improved Genoprotection against UV-Induced DNA Damage in a Resveratrol and its Related Polyphenols Contribute to the Maintenance of DNA damage and DNA protection from digested raw and griddled green pepper (poly)phenols in human colorectal adenocarcinoma cells (HT-29) Consumption of anthocyanin-rich beverages affects Nrf2 and Nrf2-dependent gene transcription in peripheral lymphocytes and DNA integrity of healthy volunteers Genoprotective effects of the green tea-derived polyphenol/epicatechin gallate in C6 astroglial cells Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells Genoprotective effects of green tea (Camellia sinensis) in human subjects: Results of a controlled supplementation trial Crosstalk of reactive oxygen species and NF-κB signaling Bioactive food components, inflammatory targets, and cancer prevention Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-beta1/Smad pathway Dietary fiber enhances a tumor suppressor signaling pathway in the gut Apple peel polyphenols and their beneficial actions on oxidative stress and inflammation Apple peel polyphenols reduce mitochondrial dysfunction in mice with DSS-induced ulcerative colitis Apple peel polyphenols: A key player in the prevention and treatment of experimental inflammatory bowel disease Epigenetic reprogramming in metabolic disorders: Nutritional factors and beyond Identification of DNA-Methylated CpG Islands Associated With Gene Silencing in the Adult Body Tissues of the Ogye Chicken Using RNA-Seq and Reduced Representation Bisulfite Sequencing Regulation of chromatin by histone modifications Chapter Seven-MicroRNAs and Epigenetics Epigenetic priming of the metabolic syndrome Raspberry Polyphenols Attenuate High-Fat Diet-Driven Activation of NLRP3 Inflammasome and its Paracrine Suppression of Adipogenesis via Histone Modifications Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats Prevention of diet-induced obesity by apple polyphenols in Wistar rats through regulation of adipocyte gene expression and DNA methylation patterns Cocoa Consumption Alters the Global DNA Methylation of Peripheral Leukocytes in Humans with Cardiovascular Disease Risk Factors: A Randomized Controlled Trial Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: Role of miR-155 Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD Epigallocatechin-3-O-gallate up-regulates microRNA-199a-3p expression by down-regulating the expression of cyclooxygenase-2 in stimulated human osteoarthritis chondrocytes The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation Hydroxytyrosol Modulates Adipocyte Gene and miRNA Expression Under Inflammatory Condition Effect of Green and Brown Propolis Extracts on the Expression Levels of microRNAs, mRNAs and Proteins, Related to Oxidative Stress and Inflammation Global microRNA expression profiling: Curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells Polyphenolics from açaí (Euterpe oleracea Mart.) and red muscadine grape (Vitis rotundifolia) protect human umbilical vascular Endothelial cells (HUVEC) from glucose-and lipopolysaccharide (LPS)-induced inflammation and target microRNA-126 Involvement of miR-Let7A in inflammatory response and cell survival/apoptosis regulated by resveratrol in THP-1 macrophage Effect of quercetin on inflammatory gene expression in mice liver in vivo-Role of redox factor 1, miRNA-122 and miRNA-125b Ameliorative effect of grapre seed extract on metabolic disorders caused by high fat diet induced obesity in rats by reversing the indrease inhepatic miR-33a and miR-122. Afr Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway Polyphenol-rich green tea extract improves adipose tissue metabolism by down-regulating miR-335 expression and mitigating insulin resistance and inflammation Involvement of miR-539-5p in the inhibition of de novo lipogenesis induced by resveratrol in white adipose tissue One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites Radical scavenger activity of three flavonoid metabolites studied by inhibition of chemiluminescence in human PMNs 3,4-Dihydroxyphenylacetic acid is a predominant biologically-active catabolite of quercetin glycosides 3,4-Dihydroxyphenylacetic acid is a potential aldehyde dehydrogenase inducer in murine hepatoma Hepa1c1c7 cells Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function Colonic metabolites from flavanols stimulate nitric oxide production in human endothelial cells and protect against oxidative stress-induced toxicity and endothelial dysfunction Microbial phenolic metabolites improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl hydroperoxide-induced toxicity via ERKs and PKC pathways 3,4-Dihydroxyphenylacetic acid, a microbiotaderived metabolite of quercetin, protects against pancreatic beta-cells dysfunction induced by high cholesterol Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic C-ring cleavage of flavonoids by human intestinal bacteria Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria Insights into the intestinal bacterial metabolism of flavonoids and the bioactivities of their microbe-derived ring cleavage metabolites The Bioavailability of Apigenin-7-Glucoside Is Influenced by Human Intestinal Microbiota in Rats The pig caecum model: A suitable tool to study the intestinal metabolism of flavonoids Human intestinal microbial metabolism of naringin Metabolism of dietary soy isoflavones to equol by human intestinal microflora-Implications for health Effect of S-equol and Soy Isoflavones on Heart and Brain The antioxidant activity of daidzein metabolites, O-desmethylangolensin and equol, in HepG2 cells Anaerobic degradation of flavonoids by Eubacterium ramulus Flavanol monomer-induced changes to the human faecal microflora Phenyl-γ-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: Synthesis, analysis, bioavailability, and bioactivity The metabolome of [2-14C](−)-epicatechin in humans: Implications for the assessment of efficacy, safety, and mechanisms of action of polyphenolic bioactives Phenyl-γ-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives Facilitated cellular uptake and suppression of inducible nitric oxide synthase by a metabolite of maritime pine bark extract (Pycnogenol). Free Radic 5-(3',4'-Dihydroxyphenyl-gamma-valerolactone), a Major Microbial Metabolite of Proanthocyanidin, Attenuates THP-1 Monocyte-Endothelial Adhesion Effects of Metabolites Produced from (−)-Epigallocatechin Gallate by Rat Intestinal Bacteria on Angiotensin I-Converting Enzyme Activity and Blood Pressure in Spontaneously Hypertensive Rats Vasorelaxant activity of twenty-one physiologically relevant (poly)phenolic metabolites on isolated mouse arteries Chemical Profile and Antioxidative and Antimicrobial Activity of Juices and Extracts of 4 Black Currants Varieties (Ribes nigrum L.) In vitro metabolism of anthocyanins by human gut microflora Protocatechuic acid is the major human metabolite of cyanidin-glucosides Colonic metabolites of berry polyphenols: The missing link to biological activity? Antioxidant and antidiabetic activity of blackberry after gastrointestinal digestion and human gut microbiota fermentation Elderberry and Elderflower Extracts, Phenolic Compounds, and Metabolites and Their Effect on Complement, RAW 264.7 Macrophages and Dendritic Cells Esterase activity able to hydrolyze dietary antioxidant hydroxycinnamates is distributed along the intestine of mammals Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid Identification of Urolithin A as a Metabolite Produced by Human Colon Microflora from Ellagic Acid and Related Compounds Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy Effect of ellagic acid on gastric damage induced in ischemic rat stomachs following ammonia or reperfusion Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: Studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression Antioxidative properties of functional polyphenols and their metabolites assessed by an ORAC assay Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: Possible involvement of NADPH oxidase-derived reactive oxygen species Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells Enterodiol and enterolactone modulate the immune response by acting on nuclear factor-kappaB (NF-kappaB) signaling Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone In Vitro Metabolism of Plant Lignans: New Precursors of Mammalian Lignans Enterolactone and Enterodiol Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity Influence of glucuronidation and reduction modifications of resveratrol on its biological activities In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota Berry (poly)phenols and cardiovascular health 4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-κB signaling The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies The potential health effects of dietary phytoestrogens Soy isoflavones and their relationship with microflora: Beneficial effects on human health in equol producers Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: A pilot study Dietary factors influence production of the soy isoflavone metabolite s-(−)equol in healthy adults Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status Effects of Equol Supplement on Bone and Cardiovascular Parameters in Middle-Aged Japanese Women: A Prospective Observational Study The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: A systematic review of randomised controlled trials Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. women Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein Dietary intake of 337 polyphenols in French adults Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: A randomised, controlled, double-masked trial: The Flaviola Health Study Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance Bioavailability and pharmacokinetic profile of grape pomace phenolic compounds in humans The immune response in atherosclerosis: A double-edged sword Cranberry (poly)phenol metabolites correlate with improvements in vascular function: A double-blind, randomized, controlled, dose-response, crossover study Green Tea Extract Treatment in Obese Mice with Nonalcoholic Steatohepatitis Restores the Hepatic Metabolome in Association with Limiting Endotoxemia-TLR4-NFκB-Mediated Inflammation Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats Ellagic acid metabolism by human gut microbiota: Consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A Immunochemical detection of food-derived polyphenols in the aorta: Macrophages as a major target underlying the anti-atherosclerotic activity of polyphenols The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome Could Fecal Phenylacetic and Phenylpropionic Acids Be Used as Indicators of Health Status? Ellagic Acid and Its Microbial Metabolite Urolithin A Alleviate Diet-Induced Insulin Resistance in Mice Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice Health effects with consumption of the flax lignan secoisolariciresinol diglucoside Potential protective properties of flax lignan secoisolariciresinol diglucoside Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat Reasons for not meeting coronary artery disease targets of care in ambulatory practice Dietary Lignans: Definition, Description and Research Trends in Databases Development Impact of lignans in oilseed mix on gut microbiome composition and enterolignan production in younger healthy and premenopausal women: An in vitro pilot study A Review of Lignan Metabolism, Milk Enterolactone Concentration, and Antioxidant Status of Dairy Cows Fed Flaxseed Association of Polyphenol Biomarkers with Cardiovascular Disease and Mortality Risk: A Systematic Review and Meta-Analysis of Observational Studies Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: A prospective investigation in two cohorts of U.S. women The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults Therapeutic potential of resveratrol: The in vivo evidence Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats Resveratrol and diabetes: From animal to human studies Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice The effects of trans-resveratrol on insulin resistance, inflammation, and microbiota in men with the metabolic syndrome: A pilot randomized, placebo-controlled clinical trial Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography